FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3760911 · Received April 21, 2014

Report

Report Number
2124215-2014-08847
Event Type
Malfunction
Date Received
April 21, 2014
Date of Event
July 28, 2012
Report Date
February 20, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE RIGHT VENTRICULAR (RV) DEFIBRILLATION LEAD EXHIBITED HIGH OUT OF RANGE RV PACING IMPEDANCES GREATER THAN 2,000 OHMS. NO ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONAL INFORMATION WAS PROVIDED THAT THE PATIENT WAS SEEN IN CLINIC AND A FULL EVALUATION WAS PERFORMED OF THE PATIENT'S SYSTEM. THE RV LEAD IMPEDANCES VARIED FROM 1,989 TO GREATER THAN 2,000 OHMS. IT WAS NOTED THAT MOST MEASUREMENTS WERE LESS THAN 2,000 OHMS AND THRESHOLD AND SENSING MEASUREMENTS WERE FOUND TO BE STABLE, AND THERE WAS NO NOISE FOUND ON THE INTRACARDIAC ELECTROGRAMS. IT WAS ADDITIONALLY NOTED THAT THE PATIENT DOES NOT SIGNIFICANTLY PACE IN THE VENTRICLE AND HAS NORMAL SINUS RHYTHM FOR AN UNDERLYING RHYTHM, THUS THE PHYSICIAN WAS COMFORTABLE WITH CONTINUED MONITORING OF THE LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE DEVICE REMAINS IMPLANTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
239382 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWP GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 77 YR E110| T165| 4470| 0185